Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CXCL1 |
| Upstream (Parents) |
|---|
| (<<) CDCP1 → CXCL1 |
| (<<) CDKN1A → CXCL1 |
| (<<) CXCL2 → CXCL1 |
| (<<) CXCL3 → CXCL1 |
| (<<) IL1B → CXCL1 |
| (<<) ITGB4 → CXCL1 |
| (<<) JUNB → CXCL1 |
| (<<) PLAU → CXCL1 |
| Downstream (Children) |
|---|
| CXCL1 → ADAM19 (>>) |
| CXCL1 → ATP2C1 (>>) |
| CXCL1 → ATP7B (>>) |
| CXCL1 → FGF5 (>>) |
| CXCL1 → FZD1 (>>) |
| CXCL1 → KLK10 (>>) |
| CXCL1 → MAP3K8 (>>) |
| CXCL1 → MMP7 (>>) |
| CXCL1 → PI3 (>>) |
| CXCL1 → PTGS2 (>>) |
| CXCL1 → RAP1A (>>) |
| CXCL1 → RHOF (>>) |
| CXCL1 → RPS6KB1 (>>) |
